Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4285410
Max Phase: Preclinical
Molecular Formula: C26H26N4O
Molecular Weight: 410.52
Molecule Type: Small molecule
Associated Items:
ID: ALA4285410
Max Phase: Preclinical
Molecular Formula: C26H26N4O
Molecular Weight: 410.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2nccc(-c3cncnc3)c2c(C)c1-c1ccc(CN2CCOCC2)cc1
Standard InChI: InChI=1S/C26H26N4O/c1-18-13-24-26(23(7-8-29-24)22-14-27-17-28-15-22)19(2)25(18)21-5-3-20(4-6-21)16-30-9-11-31-12-10-30/h3-8,13-15,17H,9-12,16H2,1-2H3
Standard InChI Key: IFLNWDKYQWGWAZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 410.52 | Molecular Weight (Monoisotopic): 410.2107 | AlogP: 4.81 | #Rotatable Bonds: 4 |
Polar Surface Area: 51.14 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.19 | CX LogP: 4.25 | CX LogD: 4.04 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.48 | Np Likeness Score: -0.90 |
1. Fang C, Lee KK, Nietupski R, Bates RH, Fernandez-Menendez R, Lopez-Roman EM, Guijarro-Lopez L, Yin Y, Peng Z, Gomez JE, Fisher S, Barros-Aguirre D, Hubbard BK, Serrano-Wu MH, Hung DT.. (2018) Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors., 28 (22): [PMID:30316633] [10.1016/j.bmcl.2018.09.037] |
Source(1):